ArticleScience signaling2014

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer.

Jessica J Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.